DP2
Dược phẩm Trung ương 2 ·UPCOM ·2026Q1
▼▼ Declining sharply
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, DP2 posted a very sharp profit drop versus the same period, showing that pressure has clearly fed through to the bottom line. More notably, profit relies heavily on non-core sources while operating cash flow is negative — these two factors together suggest earnings quality needs cautious evaluation.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.4 | 45.0 | 49.9 | 62.7 | 41.5 | 51.8 | 43.8 | 59.7 | 44.9 | 44.5 | 37.6 | 56.1 |
| Growth | -35% | -10% | -20% | +51% | -20% | +18% | -27% | +33% | +1% | +18% | -33% | — |
| Net Income | -6.9 | -4.9 | -2.4 | 0.5 | -3.5 | 2.4 | -5.8 | -0.3 | -1.4 | -10.1 | -4.6 | -6.1 |
| Net Margin | -23.46% | -10.92% | -4.81% | 0.74% | -8.32% | 4.55% | -13.28% | -0.55% | -3.11% | -22.78% | -12.11% | -10.78% |
Drivers of DP2's profit
Net profit attributable to parent declined vs last year, mainly due to higher finance costs. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from -8.9% to -19.5% — net margin weakened the most, though asset turnover and leverage still provided support.
Is the profit sustainable?
Margins are under pressure while earnings still rely significantly on non-core sources.
What is driving the margin?
Net margin fell to -7.35%, losing 3.7pp. The main pressure is SG&A / Revenue rose 0.7pp, outweighing the improvement in Gross margin rose 3.3pp (with lingering pressure from Net financial result / Revenue fell 4.4pp and Other profit / Revenue fell 1.9pp).
The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Watchpoints
Even though contribution decreased by 6.3pp, financial result still accounts for 124.7% of PBT — earnings durability should be monitored in coming periods.
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Leverage is very high, with clear pressure on the capital structure — liabilities at 4.85x equity, with a net cash position equivalent to 0.03x equity.
Inventory ended the period at 41.6bn, roughly 10.1% of total assets.
Over the last 12 months, working capital released 0.0bn of cash.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Cash conversion cycle lengthened by 24.3 days versus the same period last year. The main moves came from DIO rose 15.3 days, DSO fell 2.8 days, and DPO fell 11.8 days.
Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.
Watchpoints
CCC stands at 112.4 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DIO increased by +15.3 days, suggesting more capital is being tied up in inventories.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 21.7bn.
Leverage & Liquidity
Leverage warrants monitoring, with net debt / equity at -0.03x and interest coverage only at -0.74x.
At present, short-term debt accounts for 100.0% of total debt, cash equals 113.8% of debt, and total debt stands at 95.1bn.
Watchpoints
Interest coverage is -0.74x, leaving limited room to absorb financing costs.
Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 21.7bn in 2025, against investing cash flow of -0.6bn.
Post-investment cash flow was positive +21.0bn. Financing cash flow was negative +4.7bn.
CFO / net income was -1.39x.
Track how much investment can be funded internally from operating cash flow.
Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. Even so, earnings quality still needs closer monitoring because net financial result remains elevated. The main risk still sits in core profitability, with net margin down 3.7 pp.
Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for 95.5% of PBT and CFO / net income currently at -1.39x.
Key risk: profitability remains under pressure, with trailing-12M net margin at -7.35% after a 3.7pp decline versus the same period last year.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
199.0 | 200.2 | 193.2 | 188.2 | 180.0 |
|
Cost of Goods Sold
|
174.2 | 182.4 | 182.9 | 180.9 | 0.0 |
|
Gross Profit
|
24.8 | 17.7 | 10.3 | 7.3 | 7.9 |
|
Financial Expenses
|
13.2 | 5.2 | 15.8 | 14.9 | -12.1 |
|
Selling Expenses
|
3.5 | 3.9 | 4.3 | 3.8 | -2.9 |
|
General and Administrative Expenses
|
15.2 | 14.7 | 13.5 | 13.2 | -11.5 |
|
Operating Profit
|
-6.9 | -6.1 | -23.3 | -21.0 | -18.5 |
|
Profit Before Tax
|
-10.8 | -5.6 | -24.0 | -23.8 | -17.9 |
|
Net Income
|
-10.8 | -5.6 | -24.0 | -23.8 | -17.9 |
|
Profit Attributable to Parent
|
-10.8 | -5.6 | -24.0 | -23.8 | -17.9 |
|
Earnings per Share
|
-541.00 | -278.00 | -1,202.00 | -1,188.00 | -896.19 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.